BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2016
View Archived Issues
H3 Biomedicine initiates phase I study of H3B-8800 in MDS, AML and CMML
Read More
FDA grants clearance for Alere i RSV rapid molecular test
Read More
FDA approves Pfizer's Troxyca ER
Read More
Celgene Quanticel Research describes novel JARID1A/1B inhibitor at ACS
Read More
ABCB6 is a genetic modifier of the severity of hereditary porphyria
Read More
AB Science patents atitumoral agents
Read More
Bayer Pharma discloses sGC activators
Read More
F12 and STC2 genes as independent prognostic factors in breast cancer
Read More
EMA accepts Portola Pharmaceuticals' MAA for Indexxa
Read More
FDA extends iGlarLixi NDA review following submission of additional information
Read More
Cancer Research Technology develops ENPP2 inhibitors
Read More
Chinese scientists present Nav1.7 channel blockers
Read More
Phase II results demonstrate clinical activity for venetoclax monotherapy in patients with AML
Read More
Rio Grande Neurosciences terminates binding letter agreement with Endonovo Therapeutics
Read More
PATH initiates phase I trial of MCV-5 meningococcal conjugate vaccine
Read More
Randox Biochip Array Technology allows rapid determination of ApoE4 status in plasma
Read More
Shionogi initiates phase III trial of S-649266 to treat carbapenem-resistant Gram-negative bacteria
Read More
Vaccinex's VX-15 gets FDA orphan drug designation for the treatment of Huntington's disease
Read More
PZM-21 is a potent, novel mu-opioid receptor agonist with reduced side effects
Read More
New phase II trial explores safety and immunogenicity of TSI-GSD-210 for Western equine encephalitis
Read More
FDA grants tentative approval to Supernus Pharmaceuticals' NDA for Trokendi
Read More
FDA accepts IND for Zymeworks' ZW-25
Read More
Nordic Nanovector announces completion of several arms in betalutin trial
Read More
Arca Biopharma randomizes 100th patient in GENETIC-AF clinical trial
Read More
Nutrinia and Morristown close deal to fund oral insulin trials
Read More